David C. Duffy
Chief Tech/Sci/R&D Officer chez QUANTERIX CORPORATION
Profil
David C.
Duffy is currently the Chief Technology Officer & Vice President-Research at Quanterix Corp.
Prior to his current position, he worked as the Director-Pharmacomer Technology at Surface Logix LLC from 2000 to 2007 and as a Senior Scientist at Gamera Bioscience Corp from 1998 to 2000.
Dr. Duffy obtained his undergraduate, graduate, and doctorate degrees from the University of Cambridge.
Postes actifs de David C. Duffy
Sociétés | Poste | Début |
---|---|---|
QUANTERIX CORPORATION | Chief Tech/Sci/R&D Officer | 18/10/2011 |
Anciens postes connus de David C. Duffy
Sociétés | Poste | Fin |
---|---|---|
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/06/2007 |
Gamera Bioscience Corp
Gamera Bioscience Corp Medical SpecialtiesHealth Technology Part of Tecan Group AG, Gamera Bioscience Corp develops miniaturized high-throughput assays used to analyze samples. The private company is based in Boston, MA. The company was founded by Alec Humayun Mian. Gamera Bioscience was acquired by Tecan Group AG on July 21, 2000 for $10 million. | Corporate Officer/Principal | 01/01/2000 |
Formation de David C. Duffy
University of Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
QUANTERIX CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Health Technology |
Gamera Bioscience Corp
Gamera Bioscience Corp Medical SpecialtiesHealth Technology Part of Tecan Group AG, Gamera Bioscience Corp develops miniaturized high-throughput assays used to analyze samples. The private company is based in Boston, MA. The company was founded by Alec Humayun Mian. Gamera Bioscience was acquired by Tecan Group AG on July 21, 2000 for $10 million. | Health Technology |